암환자 수면 장애의 약물요법：체계적 문헌 고찰

참고문헌 (85)

1. Passik SD, "An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients", J Pain Symptom Manage, 25, pp.284~287 (2003)
2. Fiorentino L, "Insomnia and its treatment in women with breast cancer", Sleep Med Rev, 10, pp.419~429 (2006)
3. Savard J, "Insomnia in the context of cancer: a review of a neglected problem", J Clin Oncol, 19, pp.895~908 (2001)
4. Ancoli-Israel S, "The relationship between fatigue and sleep in cancer patients: a review", Eur J Cancer Care (Engl), 10, pp.245~255 (2001)
5. Berger AM, "Sleep wake disturbances in people with cancer and their caregivers: state of the science", Oncol Nurs Forum, 32, pp.E98~E126 (2005)
6. Couzi RJ, "Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy", J Clin Oncol, 13, pp.2737~2744 (1995)
7. Harrison LB, "Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue", Head Neck, 19, pp.169~175 (1997)
8. Lindley C, "Quality of life and preferences for treatment following systemic adjuvant therapy for earlystage breast cancer", J Clin Oncol, 16, pp.1380~1387 (1998)
9. Durmer JS, "Neurocognitive consequences of sleep deprivation", Semin Neurol, 25, pp.117~129 (2005)
10. "Diurnal consequence of insomnia: impact on quality of life", Rev Neurol (Paris), 157, pp.1270~1278 (2001)
11. Johnson LC, "Psychological and physiological changes following total sleep deprivation in Sleep: Physiology and Pathology", pp.206~220 (1969), Lippincott
12. Moldofsky H, "Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation", Psychosom Med, 38, pp.35~44 (1976)
13. Leger D, "SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers", Psychosom Med, 63, pp.49~55 (2001)
14. LeBlanc M, "Psychological and health-related quality of life factors associated with insomnia in a population-based sample", J Psychosom Res, 63, pp.157~166 (2007)
15. Redeker NS, "Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy", Sch Inq Nurs Pract, 14, pp.275~290 (2000)
16. Fortner BV, "Sleep and quality of life in breast cancer patients", J Pain Symptom Manage, 24, pp.471~480 (2002)
17. Zammit GK, "Quality of life in people with insomnia", Sleep, 22(Suppl 2), pp.S379~S385 (1999)
18. Breslau N, "Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults", Biol Psychiatry, 39, pp.411~418 (1996)
19. Ford DE, "Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?", JAMA, 262, pp.1479~1484 (1989)
20. Weissman MM, "The morbidity of insomnia uncomplicated by psychiatric disorders", Gen Hosp Psychiatry, 19, pp.245~250 (1997)
21. Roth T, "The relationship between psychiatric diseases and insomnia. Int J Clin Pract Suppl", 3~8 (2001)
22. Millman RP, "Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure", J Clin Psychiatry, 50, pp.348~351 (1989)
23. Moldofsky H, "Effects of sleep deprivation on human immune functions", FASEB J, 3, pp.1972~1977 (1989)
24. Stiefel FC, "Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period", Cancer, 65, pp.1048~1053 (1990)
25. Davidson JR, "Sleep disturbance in cancer patients", Soc Sci Med, 54, pp.1309~1321 (2002)
26. Harbour RT, "SIGN 50 A Guideline Developer’s Handbook" (2008), Scottish Intercollegiate Guidelines Network
27. Buysse DJ, "Chronic insomnia", Am J Psychiatry, 165, pp.678~686 (2008)
28. American Sleep Disorders Association, "The international classification of sleep disorders: Diagnostic and coding manual" (2001), American Sleep Disorders Association
29. World Health Organization, "The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines" (1992), World Health Organization
30. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2000), American Psychiatric Association
31. Spielman AJ, "A behavioral perspective on insomnia treatment", Psychiatr Clin North Am, 10, pp.541~553 (1987)
32. Sateia MJ, "Insomnia", Lancet, 364, pp.1959~1973 (2004)
33. Payne RJ, "High prevalence of obstructive sleep apnea among patients with head and neck cancer", J Otolaryngol, 34, pp.304~311 (2005)
34. Nesse W, "Prevalence of obstructive sleep apnoea following head and neck cancer treatment: a cross-sectional study", Oral Oncol, 42, pp.108~114 (2006)
35. Savard J, "Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer", Sleep, 24, pp.583~590 (2001)
36. Wilson S, "Drug treatment of chronic insomnia--dawn at the end of a long night?", J Psychopharmacol, 22, pp.703~706 (2008)
37. Mendelson WB, "The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium", Sleep Med Rev, 8, pp.7~17 (2004)
38. National Institutes of Health, "National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005", Sleep, 28, pp.1049~1057 (2005)
39. Sweetman SC, "Martindale: The Complete Drug Reference" (1999), Pharmaceutical Press
40. Holbrook AM, "Meta-analysis of benzodiazepine use in the treatment of insomnia", CMAJ, 162, pp.225~233 (2000)
41. Nowell PD, "Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy", JAMA, 278, pp.2170~2177 (1997)
42. Hirst A, "Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database Syst Rev 2002;CD003346", ~ (2002)
43. Jacobsen PB, "Hypnotic efficacy and safety of triazolam administered during the postoperative period", Gen Hosp Psychiatry, 16, pp.419~425 (1994)
44. Scharf MB, "A multicenter, placebocontrolled study evaluating zolpidem in the treatment of chronic insomnia", J Clin Psychiatry, 55, pp.192~199 (1994)
45. Perlis ML, "Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia", J Clin Psychiatry, 65, pp.1128~1137 (2004)
46. Walsh JK, "Eight weeks of non-nightly use of zolpidem for primary insomnia", Sleep, 23, pp.1087~1096 (2000)
47. Turek FW, "Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists", Sleep Med, 5, pp.523~532 (2004)
48. Brzezinski A, "Melatonin in humans", N Engl J Med, 336, pp.186~195 (1997)
49. Erman M, "An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia", Sleep Med, 7, pp.17~24 (2006)
50. Roth T, "Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia", Sleep Med, 7, pp.312~318 (2006)
51. Roth T, "A 2-night, 3-period, crossover study of ramelteon’s efficacy and safety in older adults with chronic insomnia", Curr Med Res Opin, 23, pp.1005~1014 (2007)
52. Muller HL, "Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients", J Clin Endocrinol Metab, 87, pp.3993~3996 (2002)
53. Muller HL, "Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients", J Pediatr Endocrinol Metab, 19(Suppl 1), pp.423~429 (2006)
54. Muller HL, "Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness", Cancer Causes Control, 17, pp.583~589 (2006)
55. Marcoli M, "Trazodone is a potent agonist at 5-HT2C receptors mediating inhibition of the N-methyl-D-aspartate", nitric oxide, J Pharmacol Exp Ther, pp.1998, 285[DOI]
56. Schreiber S, "The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms", Neurosci Lett, 273, pp.85~88 (1999)
57. Schreiber S, "Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?", J Mol Neurosci, 18, pp.143~149 (2002)
58. Schreiber S, "The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms", Brain Res Bull, 58, pp.601~605 (2002)
59. Razavi D, "Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study", J Int Med Res, 27, pp.264~272 (1999)
60. Curry DT, "Pharmacologic management of insomnia: past, present, and future", Psychiatr Clin North Am, 29, pp.871~893 (2006)
61. Roehrs T, "‘Hypnotic’ prescription patterns in a large managed-care population", Sleep Med, 5, pp.463~466 (2004)
62. Walsh JK, "Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia", Human Psychopharmacology: Clinical and Experimental, 13, pp.191~198 (1998)
63. Mendelson WB, "A review of the evidence for the efficacy and safety of trazodone in insomnia", J Clin Psychiatry, 66, pp.469~476 (2005)
64. Anttila SA, "A review of the pharmacological and clinical profile of mirtazapine", CNS Drug Rev, 7, pp.249~264 (2001)
65. Szegedi A, "Mirtazapine: a review of its clinical efficacy and tolerability", Expert Opin Pharmacother, 6, pp.631~641 (2005)
66. Kast RE, "Mirtazapine may be useful in treating nausea and insomnia of cancer chemotherapy", Support Care Cancer, 9, pp.469~470 (2001)
67. Cankurtaran ES, "Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine", Support Care Cancer, 16, pp.1291~1298 (2008)
68. Kim SW, "Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression", Psychiatry Clin Neurosci, 62, pp.75~83 (2008)
69. Theobald DE, "An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms", J Pain Symptom Manage, 23, pp.442~447 (2002)
70. Stimmel GL, "Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects", Pharmacotherapy, 17, pp.10~21 (1997)
71. Schweitzer PK, "Sleepiness and performance during three-day administration of cetirizine or diphenhydramine", J Allergy Clin Immunol, 94, pp.716~724 (1994)
72. Young JS, "Sleep in hospitalized medical patients, part 2: behavioral and pharmacological management of sleep disturbances", J Hosp Med, 4, pp.50~59 (2009)
73. Moore P, "Opioids, sleep, and cancer-related fatigue", Med Hypotheses, 58, pp.77~82 (2002)
74. Cherny N, "Strategies to manage the adverse effects of oral morphine: an evidence-based report", J Clin Oncol, 19, pp.2542~2554 (2001)
75. Volkow ND, "Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain", J Neurosci, 21, pp.RC121~ (2001)
76. Sood A, "Use of methylphenidate in patients with cancer", Am J Hosp Palliat Care, 23, pp.35~40 (2006)
77. Bruera E, "Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer", J Pain Symptom Manage, 4, pp.3~6 (1989)
78. Bruera E, "The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report", Pain, 50, pp.75~77 (1992)
79. Bruera E, "Methylphenidate associated with narcotics for the treatment of cancer pain", Cancer Treat Rep, 71, pp.67~70 (1987)
80. Bruera E, "Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain", Pain, 48, pp.163~166 (1992)
81. Wilwerding MB, "A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics", Support Care Cancer, 3, pp.135~138 (1995)
82. Slatkin N, "Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report", J Pain Symptom Manage, 27, pp.268~273 (2004)
83. Slatkin NE, "Treatment of opiate-related sedation: utility of the cholinesterase inhibitors", J Support Oncol, 1, pp.53~63 (2003)
84. Slatkin NE, "Donepezil in the treatment of opioid-induced sedation: report of six cases", J Pain Symptom Manage, 21, pp.425~438 (2001)
85. Bruera E, "The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study", J Pain Symptom Manage, 26, pp.1049~1054 (2003)

관련 논문AI추천